Omar, O., Abo Elmaaty, M., Ibrahim, A., Soliman, S. (2017). Role of Pet/Ct in Assessment of Post Therapeutic Hepatocellular Carcinoma. The Egyptian Journal of Hospital Medicine, 69(4), 2271-2277. doi: 10.12816/0041529
Omar Hussain Omar; Mohamed Elgharib Abo Elmaaty; Ayman Mohamed Ibrahim; Sherif Sameh Soliman. "Role of Pet/Ct in Assessment of Post Therapeutic Hepatocellular Carcinoma". The Egyptian Journal of Hospital Medicine, 69, 4, 2017, 2271-2277. doi: 10.12816/0041529
Omar, O., Abo Elmaaty, M., Ibrahim, A., Soliman, S. (2017). 'Role of Pet/Ct in Assessment of Post Therapeutic Hepatocellular Carcinoma', The Egyptian Journal of Hospital Medicine, 69(4), pp. 2271-2277. doi: 10.12816/0041529
Omar, O., Abo Elmaaty, M., Ibrahim, A., Soliman, S. Role of Pet/Ct in Assessment of Post Therapeutic Hepatocellular Carcinoma. The Egyptian Journal of Hospital Medicine, 2017; 69(4): 2271-2277. doi: 10.12816/0041529
Role of Pet/Ct in Assessment of Post Therapeutic Hepatocellular Carcinoma
Radiodiagnosis Department, Ain Shams University, Cairo, Egypt
Abstract
Aim of the work: this study aimed to highlight the role of PET/CT in evaluation of post-therapeutic hepatocellular carcinoma, hence guiding the clinician to proper management strategy. Patients and methods: 35 patients (32 male and 3 female) were included in this study. All patients had history of local treatment of HCC; most of the cases were treated with TACE or RFA. They had undergone 18F-FDG PET/CT for evaluation of the therapeutic effect after the end of the therapy. Results:our study demonstrated that 18F-FDG PET/CT is a significant prognostic factor for tumor recurrence in post-therapeutic HCC with a cutoff TSUVmax/LSUVmax value of 1.3. Conclusion:18F-FDG PET/CT imaging have a prognostic significance in evaluation of patients with post-therapeutic HCC and provide valuable information that can be used in the treatment response evaluation and clinical decision making process.
View on SCiNiTO
Top